PharmaceuticalsIngredients for each route of administration
Adapting medications to the needs of patients, such as treatment efficacy and therapeutic adherence, resolving bioavailability issues for active ingredients, are key priorities for pharmaceutical industry players.
At Seppic, being experts in formulation, polymers, surfactants, and emulsions, we offer excipients adapted to three routes of administration — oral, topical, and parenteral — as well as vaccine adjuvants. We also assist our customers in their development projects.
Effective excipients for formulators and patientsSee more Our parenteral ingredients
A rapid administrationSee more The science behind our pharmaceutical ingredients
Discover our technologies and expertise for pharmaceuticalsSee more Our latest news
Find the latest news regarding our pharmaceutical ingredientsSee more
Ingredients adapted to each route of administration
For oral administration, regardless of the form, our excipients improve the bioavailability of the active ingredients, their solubility, the formulation stability, taste-masking, and therapeutic adherence of the patient.
For topical administration, our excipients contribute to innovation in dermatology and dermopharmacy by improving therapeutic adherence or facilitating solubilization, and formulation of active ingredients in various galenic forms.
For parenteral administration, our solubilizers enhance the efficacy of active ingredients while meeting the requirements of intravenous, intramuscular or subcutaneous administration.
Vaccine adjuvants contribute to vaccine performance. For instance, they can be used in therapeutic vaccines for immunotherapy in oncology (lung cancer, breast cancer, melanoma, etc.), or in prophylactic vaccines to protect people from certain infectious diseases.
Innovative polymers and emulsifier for topical drug & MD, October 20 [...]
- October 9, 2020
- 1 min of read time
Co-development of a GMP emulsion-based adjuvant for human prophylactic [...]
- April 27, 2020
- 2 mins of read time
Seppic launches SEPIFILM™ White TF for the pharmaceutical market.
- April 29, 2019
- 1 min of read time